Management of scalp psoriasis: current perspectives

References

• LowesMASuarez-FarinasMKruegerJGImmunology of psoriasisAnnu Rev Immunol20143222725524655295
   PubMed Web of Science ®Google Scholar
• RappSRFeldmanSRExumMLFleischerABJrReboussinDMPsoriasis causes as much disability as other major medical diseasesJ Am Acad Dermatol1999413 Pt 140140710459113
   PubMed Web of Science ®Google Scholar
• HenselerTChristophersEPsoriasis of early and late onset: characterization of two types of psoriasis vulgarisJ Am Acad Dermatol19851334504564056119
   PubMed Web of Science ®Google Scholar
• MenterAGottliebAFeldmanSRGuidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologicsJ Am Acad Dermatol200858582685018423260
   PubMed Web of Science ®Google Scholar
• ChanCSVan VoorheesASLebwohlMGTreatment of severe scalp psoriasis: from the Medical Board of the National Psoriasis FoundationJ Am Acad Dermatol200960696297119375191
   PubMed Web of Science ®Google Scholar
• PappKBerth-JonesJKragballeKWozelGde la BrassinneMScalp psoriasis: a review of current topical treatment optionsJ Eur Acad Dermatol Venereol20072191151116017894698
   PubMed Web of Science ®Google Scholar
• CrowleyJScalp psoriasis: an overview of the disease and available therapiesJ Drugs Dermatol20109891291820684141
   PubMed Web of Science ®Google Scholar
• LebwohlMGBachelezHBarkerJPatient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis SurveyJ Am Acad Dermatol201470587188124576585
   PubMed Web of Science ®Google Scholar
• GeorgeSMTaylorMRFarrantPBPsoriatic alopeciaClin Exp Dermatol201540771772126202646
   PubMed Web of Science ®Google Scholar
• FredrikssonTPetterssonUSevere psoriasis–oral therapy with a new retinoidDermatologica19781574238244357213
   PubMedGoogle Scholar
• SpulsPILecluseLLPoulsenMLBosJDSternRSNijstenTHow good are clinical severity and outcome measures for psoriasis?: quantitative evaluation in a systematic reviewJ Invest Dermatol2010130493394320043014
   PubMed Web of Science ®Google Scholar
• ChalmersRJAssessing psoriasis severity and outcomes for clinical trials and routine clinical practiceDermatol Clin2015331577125412783
   PubMed Web of Science ®Google Scholar
• FinlayAYKhanGKDermatology Life Quality Index (DLQI)–a simple practical measure for routine clinical useClin Exp Dermatol19941932102168033378
   PubMed Web of Science ®Google Scholar
• ChenSCYeungJChrenMMScalpdex: a quality-of-life instrument for scalp dermatitisArch Dermatol2002138680380712056963
   PubMedGoogle Scholar
• van de KerkhofPCFranssenMEPsoriasis of the scalp. Diagnosis and managementAm J Clin Dermatol20012315916511705093
   PubMedGoogle Scholar
• OlanskySWhole coal tar shampoo: a therapeutic hair repair systemCutis1980251991047353401
   PubMed Web of Science ®Google Scholar
• LoweNJBreedingJHWortzmanMSNew coal tar extract and coal tar shampoos. Evaluation by epidermal cell DNA synthesis suppression assayArch Dermatol198211874874897092274
   PubMedGoogle Scholar
• MasonARMasonJMCorkMJHancockHDooleyGTopical treatments for chronic plaque psoriasis of the scalp: a systematic reviewBr J Dermatol2013169351952723796133
   PubMed Web of Science ®Google Scholar
• JarrattMBrenemanDGottliebABPoulinYLiuYFoleyVClobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasisJ Drugs Dermatol20043436737315303780
   PubMedGoogle Scholar
• ReygagnePMrowietzUDecroixJClobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: a randomized comparison of efficacy and safety in subjects with scalp psoriasisJ Dermatolog Treat2005161313615897165
   PubMed Web of Science ®Google Scholar
• PoulinYPappKBissonnetteRClobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasisJ Dermatolog Treat201021318519220131980
   PubMed Web of Science ®Google Scholar
• ArnoldWPTarvan de KerkhofPCThe management of psoriasis. Clin Dermatol199715739744
   Google Scholar
• WheelerLASapersteinMDLoweNJMutagenicity of urine from psoriatic patients undergoing treatment with coal tar and ultraviolet lightJ Invest Dermatol19817721811857276613
   PubMed Web of Science ®Google Scholar
• RoelofzenJHAbenKKOldenhofUTNo increased risk of cancer after coal tar treatment in patients with psoriasis or eczemaJ Invest Dermatol2010130495396120016499
   PubMed Web of Science ®Google Scholar
• AshtonREAndrePLoweNJWhitefieldMAnthralin: historical and current perspectivesJ Am Acad Dermatol1983921731926309924
   PubMed Web of Science ®Google Scholar
• FuchsJPackerLInvestigations of anthralin free radicals in model systems and in skin of hairless miceJ Invest Dermatol19899256776822541207
   PubMed Web of Science ®Google Scholar
• MahrleGBonnekohBWeversAHegemannLAnthralin: how does it act and are there more favourable derivatives?Acta Derm Venereol Suppl (Stockh)199418683848073848
   PubMedGoogle Scholar
• SofenHHudsonCPCook-BoldenFEClobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trialJ Drugs Dermatol201110888589221818510
   PubMed Web of Science ®Google Scholar
• FranzTJParsellDAMyersJAHanniganJFClobetasol propionate foam 0.05%: a novel vehicle with enhanced deliveryInt J Dermatol200039753553810940121
   PubMed Web of Science ®Google Scholar
• MazzottaAEspositoMCarboniISchipaniCChimentiSClobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasisJ Dermatolog Treat2007182848717520464
   PubMed Web of Science ®Google Scholar
• FranzTJParsellDAHalualaniRMHanniganJFKalbachJPHarkonenWSBetamethasone valerate foam 0.12%: a novel vehicle with enhanced delivery and efficacyInt J Dermatol199938862863210487457
   PubMed Web of Science ®Google Scholar
• AndreassiLGiannettiAMilaniMScale Investigators GroupEfficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: an open, multicentre, randomized, controlled, cross-over study on 241 patientsBr J Dermatol2003148113413812534607
   PubMed Web of Science ®Google Scholar
• FeldmanSRRavisSMFleischerABJrBetamethasone valerate in foam vehicle is effective with both daily and twice a day dosing: a single-blind, open-label study in the treatment of scalp psoriasisJ Cutan Med Surg20015538638911907847
   PubMed Web of Science ®Google Scholar
• ZaghloulSSGoodfieldMJObjective assessment of compliance with psoriasis treatmentArch Dermatol2004140440841415096368
   PubMedGoogle Scholar
• ReichrathJMullerSMKerberABaumHPBahmerFABiologic effects of topical calcipotriol (MC 903) treatment in psoriatic skinJ Am Acad Dermatol199736119288996256
   PubMed Web of Science ®Google Scholar
• ReichrathJPerezAMullerSMTopical calcitriol (1,25-dihydroxyvitamin D3) treatment of psoriasis: an immunohistological evaluationActa Derm Venereol19977742682729228216
   PubMed Web of Science ®Google Scholar
• GreenCGanpuleMHarrisDComparative effects of calcipotriol (MC903) solution and placebo (vehicle of MC903) in the treatment of psoriasis of the scalpBr J Dermatol199413044834878186114
   PubMed Web of Science ®Google Scholar
• BarnesLAltmeyerPForstromLStenstromMHLong-term treatment of psoriasis with calcipotriol scalp solution and creamEur J Dermatol200010319920410725818
   PubMed Web of Science ®Google Scholar
• van der VleutenCJvan de KerkhofPCManagement of scalp psoriasis: guidelines for corticosteroid use in combination treatmentDrugs200161111593159811577796
   PubMed Web of Science ®Google Scholar
• KragballeKHoffmannVTanJCalcipotriene plus betamethasone dipropionate gel compared to calcipotriene solution in patients with scalp psoriasisJ Am Acad Dermatol2008582 Suppl 2AB131
   Web of Science ®Google Scholar
• LugerTACambazardFLarsenFGA study of the safety and efficacy of calcipotriol and betamethasone dipropionate scalp formulation in the long-term management of scalp psoriasisDermatology2008217432132818787325
   PubMed Web of Science ®Google Scholar
• TyringSMendozaNAppellMA calcipotriene/betamethasone dipropionate two-compound scalp formulation in the treatment of scalp psoriasis in Hispanic/Latino and Black/African American patients: results of the randomized, 8-week, double-blind phase of a clinical trialInt J Dermatol201049111328133320964660
   PubMed Web of Science ®Google Scholar
• GooderhamMDebarreJMKeddy-GrantJXuZKurvitsMGoodfieldMSafety and efficacy of calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis in adolescents 12–17 years of ageBr J Dermatol2015171614701477
   Web of Science ®Google Scholar
• EichenfieldLFGanslandtCKurvitsMSchlessingerJSafety and efficacy of calcipotriene plus betamethasone dipropionate topical suspension in the treatment of extensive scalp psoriasis in adolescents ages 12 to 17 yearsPediatr Dermatol2015321283525412565
   PubMed Web of Science ®Google Scholar
• TaraskaVTuppalROlesenMBang PedersenCPappKA Novel Aerosol Foam Formulation of Calcipotriol and Betamethasone Has No Impact on HPA Axis and Calcium Homeostasis in Patients With Extensive Psoriasis VulgarisJ Cutan Med Surg2016201445126224733
   PubMed Web of Science ®Google Scholar
• Queille-RousselCOlesenMVillumsenJLacourJPEfficacy of an innovative aerosol foam formulation of fixed combination calcipotriol plus betamethasone dipropionate in patients with psoriasis vulgarisClin Drug Investig2015354239245
   PubMed Web of Science ®Google Scholar
• RichPGooderhamMBachelezHApremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2)J Am Acad Dermatol201674113414226549249
   PubMed Web of Science ®Google Scholar
• MooreAGordonKBKangSA randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasisJ Am Acad Dermatol200756459860317113190
   PubMed Web of Science ®Google Scholar
• BagelJLyndeCTyringSKricorianGShiYKlekotkaPModerate to severe plaque psoriasis with scalp involvement: a randomized, double-blind, placebo-controlled study of etanerceptJ Am Acad Dermatol2012671869222014541
   PubMed Web of Science ®Google Scholar
• ThaciDUnnebrinkKSundaramMSoodSYamaguchiYAdalimumab for the treatment of moderate to severe psoriasis: subanalysis of effects on scalp and nails in the BELIEVE studyJ Eur Acad Dermatol Venereol201529235336024846518
   PubMed Web of Science ®Google Scholar
• MenterAReichKLiSConsistency of infliximab response in different body regions for treatment of moderate to severe psoriasis: Results from controlled clinical trialsJ Am Acad Dermatol200858supplAB120 Abstract 2607
   Google Scholar
• KalbREBlauveltASofenHLEffect of infliximab on health-related quality of life and disease activity by body region in patients with moderate-to-severe psoriasis and inadequate response to etanercept: results from the PSUNRISE trialJ Drugs Dermatol201312887488023986160
   PubMed Web of Science ®Google Scholar
• Di CesareAFargnoliMCPerisKRapid response of scalp psoriasis to ustekinumabEur J Dermatol201121699399421856561
   PubMed Web of Science ®Google Scholar
• PapadavidEFerraDKoumakiDUstekinumab induces fast response and maintenance of very severe refractory scalp psoriasis: results in two Greek patients from the psoriasis hospital-based clinicDermatology2014228210711124504077
   PubMed Web of Science ®Google Scholar
• LangleyRGRichPMenterAImprovement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasisJ Eur Acad Dermatol Venereol20152991763177025693783
   PubMed Web of Science ®Google Scholar
• LebwohlMQureshiAKianifardFSecukinumab in the treatment of moderate to severe scalp psoriasis: A study to evaluate efficacy and safetyJ Am Acad Dermatol2015725 suppl 1AB250
   Google Scholar
• TanejaARacetteAGourgouliatosZTaylorCRBroad-band UVB fiber-optic comb for the treatment of scalp psoriasis: a pilot studyInt J Dermatol200443646246715186234
   PubMed Web of Science ®Google Scholar
• TaylorCRRacetteALA 308-nm excimer laser for the treatment of scalp psoriasisLasers Surg Med200434213614015004825
   PubMed Web of Science ®Google Scholar